Kolotiolomq Silue
About Kolotiolomq Silue
Kolotiolomq Silue is Vice President of the abrdn World Healthcare Fund (THW) and other related funds, serving since 2024; he is currently a Senior Product Manager at abrdn Inc. and previously was a Senior Manager of Fund Administration at Tekla Capital Management. He was born in 1977 and joined abrdn Inc. in October 2023 before being appointed Fund officer in 2024 . The proxy does not disclose fund-level pay-for-performance metrics (e.g., TSR, revenue/EBITDA growth) tied to Silue’s compensation; officers are compensated by abrdn Inc. rather than by THW .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| abrdn Inc. | Senior Product Manager | Oct 2023–present | Product management and governance support for registered investment companies; leads product aspects supporting THW . |
| Tekla Capital Management LLC | Senior Manager, Fund Administration | Not disclosed (ended Oct 2023) | Fund administration for healthcare-focused funds; operations/process expertise applicable to THW . |
External Roles
No external public company board roles, committee positions, or other directorships for Silue are disclosed in the proxy .
Fixed Compensation
| Component | THW Disclosure | Notes |
|---|---|---|
| Base salary | Not disclosed | Officers are paid by abrdn Inc. (administrator/adviser), not by THW; executive officers received no compensation from THW . |
| Target bonus % | Not disclosed | Fund does not disclose officer incentive targets; officers compensated by abrdn Inc. . |
| Actual bonus paid | Not disclosed | No fund-level officer compensation disclosed . |
| Pension/SERP | Not disclosed | “None of the Funds have any bonus, profit sharing, pension or retirement plans” . |
| Perquisites | Not disclosed | No fund-level disclosure for officers; compensation is through abrdn Inc. . |
Performance Compensation
| Metric | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| Officer performance awards at THW | N/A | N/A | N/A | N/A | N/A |
| — Notes: Officers of the Funds are employees of abrdn Inc. and do not receive compensation from THW; the Funds do not maintain bonus/profit-sharing plans . |
Equity Ownership & Alignment
- Officer-specific beneficial ownership (including Silue) is not individually reported in the proxy; in aggregate, each Fund’s Trustees and officers owned less than 1% of the Fund’s outstanding equity securities as of April 1, 2025 .
- No disclosure on officer hedging, pledging, or stock ownership guidelines for THW officers in the proxy .
- Officer appointment cadence: Officers are appointed annually and serve until a successor has been duly elected and qualifies .
Employment Terms
| Term Element | Disclosure |
|---|---|
| Employment start date | Vice President since 2024; joined abrdn Inc. in Oct 2023 . |
| Contract term/expiration | Officers are appointed annually by the Fund Board and serve until a successor is elected; specific employment agreements with abrdn Inc. are not disclosed by THW . |
| Severance | Not disclosed at the Fund level . |
| Change-of-control economics | Not disclosed at the Fund level . |
| Non-compete / Non-solicit / Garden leave | Not disclosed . |
| Post-termination consulting | Not disclosed . |
Investment Implications
- Alignment: With officer compensation paid by abrdn Inc. and not THW, there are no fund-disclosed equity or bonus structures for Silue that could create near-term fund-level vesting or selling pressure; aggregate insider ownership is <1%, indicating limited direct fund equity alignment from officers and Trustees overall .
- Transparency: Lack of disclosure on severance/change-of-control and performance-based awards at the Fund level limits visibility into retention economics and pay-for-performance alignment for Silue specifically; any such terms would be governed by abrdn Inc. and not reported by THW .
- Governance: Officers are appointed annually, while independent oversight is provided by the Fund’s Board and committees; however, this oversight does not extend to disclosing officer compensation terms at the adviser level .
Citations:
Officer biography and role details .
Officer and fund-level compensation disclosures .
Ownership aggregation and lack of individual officer holdings disclosure .
Officer appointment and term mechanics .
Board and committee oversight context .